跳到正文
原文
The Lancet· @TheLancet · X·· 2026-10-04AI 评分22
AI 导读

立体定向体部放疗(SBRT)是早期、医学上不可手术的非小细胞肺癌(NSCLC)的标准治疗。 一项试验研究了在SBRT基础上联合新辅助、同步和辅助阿替利珠单抗:http://spkl.io/60177p0BW #ERSCongress @EuroRespSoc

正文

Stereotactic body radiation therapy (SBRT) is the standard of care for early-stage, medically inoperable non-small-cell lung cancer (NSCLC).

A trial investigated the addition of neoadjuvant, concurrent, and adjuvant atezolizumab with SBRT: http://spkl.io/60177p0BW #ERSCongress @EuroRespSoc

来源:The Lancet · x.com